Hemanext ONE® Oxygen-Controlled RBCs
Red Blood Cell Transfusion (Chronic Transfusion-Dependent Anemias, Critical Care/Resuscitation)
Key Facts
About Hemanext
Hemanext is a private medical device company pioneering oxygen-controlled technology for red blood cell storage. Its core innovation, the Hemanext ONE® system, processes and stores RBCs in a low-oxygen (hypoxic) environment to mitigate storage lesions, thereby preserving cell viability and function closer to their natural state. The company targets two primary markets: improving care for chronically transfused patients (e.g., with sickle cell disease) and enhancing resuscitation outcomes in critical care/trauma. With a CMS reimbursement code established, Hemanext is positioned to commercialize its technology and redefine standards in transfusion medicine.
View full company profile